Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218569 · ClinicalTrials.gov registry record · Phase 2
Combined Treatment for Cocaine-Alcohol Dependence - 1
A Phase 2 study of Alcohol Dependence and Cocaine Dependence, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT00218569 is a Phase 2 study of Alcohol Dependence and Cocaine Dependence that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 87 participants, below the 312-participant average among 43 other Alcohol Dependence trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00218569, a Phase 2 study of Alcohol Dependence and Cocaine Dependence, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine whether Naltrexone and cognitive behavioral therapy can be helpful in patients who want to stop using cocaine and alcohol.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Naltrexone
Study Locations (1)
Texas
- University of Texas Health Sci Cntr Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2003-04 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218569
The ClinicalTrials.gov registry entry for NCT00218569 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 312-participant average among 43 other Alcohol Dependence trials with a reported enrollment target (72% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Alcohol Dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00218569 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00218569 about?
NCT00218569 is a clinical study titled "Combined Treatment for Cocaine-Alcohol Dependence - 1". The purpose of this study is to examine whether Naltrexone and cognitive behavioral therapy can be helpful in patients who want to stop using cocaine and alcohol.
What is the current status of trial NCT00218569?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 87 participants. The study started on 2003-04. Estimated completion is 2007-12.
What conditions does trial NCT00218569 study?
This clinical trial studies the following conditions: Alcohol Dependence, Cocaine Dependence.
What interventions are being tested in trial NCT00218569?
The interventions under investigation include: Placebo (DRUG), Naltrexone (DRUG).
Who is sponsoring clinical trial NCT00218569?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00218569 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psilocybin or Ketamine for Alcohol Use Disorder: An Active Comparator Trial
RECRUITING · Phase 2
-
Gabapentin Treatment of Alcohol Dependence
COMPLETED · Phase 2
-
The MEADOW PROJECT (Mending the Effects of Alcohol and Depression on Women) and The Bridge Program (Connecting Recovery Treatment and Behavioral Health)
COMPLETED · Phase 2
-
Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence
COMPLETED · Phase 2
-
A Therapeutic Workplace for Alcohol Dependence
COMPLETED · Phase 2
-
Modification of Cognitive Processing Therapy (CPT-C) for PTSD and Alcohol Dependence
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.